ALKS

#1228
Alkermes Inc. plc
33.75 USD
+1.17%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
33.75
33.75
Year Range
25.16
36.48
Daily Change
+1.17%
Monthly Change
+20.71%
6 month change
+5.47%
Year Change
+24.17%
Previous Close
33.36
Open
33.75
Bid
Ask
Low
33.75
High
33.75
Volume
138
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 5.62 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.57
Price to sales ratio
3.2

Alkermes plc

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

News